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MethiciIlin-resistant Staphylococcus aureus (MRSA) has become one of the
most important nosocomial pathogens worldwide and poses serious infec-
tion control problems. As a rule, MRSA are multiresistant against many
antibiotics and increasingly vancomycin-type glycopeptides remain the only
rational treatment available. Recently, S. aureus strains with drastically
diminished vancomycin susceptibility have been isolated. first in Japan and
meanwhile in various regions of the world. Glycopeptide antibiotics exert
their action by interfering with the final steps ofbacterial cell wall synthesis
occurring at the outside of the bacterial cell. Remarkably, their mode of
action does not involve direct interference with the corresponding enzymes
(transpeptidases and transglycosylases) but binding to the enzyme substrates,
muropeptide building blocks. Analysis of the cell wall architecture of
laboratory mutants and. more important. clinical isolates reveal that present
GISA isolates can achieve reduced glycopeptide susceptibility by several
unrelated changes in amount and composition ofcell wall building blocks. In
spite of these distinct mechanisms. a unifying scheme quite distinct from that
described earlier for vancomyein-resistant enterococci will bc discussed.
Detailed understanding of the molecular resistance mechanisms and the
various factors involved in resistance phenoType expression is a prerequisite
to influence further spread of multiresistant staphylococci and to arrive at
new therapeutic alternatives.
IMoS2S1 Glycopeptide resistance in Staphylococcus auteUs
(GISA): Measures needed for control
J. Linares
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The recent description in Japan, USA. France and Spain of methicillin
resistant S. aureus (MRSA) isolates with intermediate resistance to glyco-
peptides is of great concern. Recent surveys from different countries show
that there have been no major changes in susceptibility to glycopeptides in S.
aureus in the last decade, but GISA strains may have been missed because
these studies did not use optimal methods for their detection. In our hospital
927 patients (0.4 cases/loo adm.) acquiredMRSA fromJan 1990 to Dec 1998
and the majority of infections were caused by a multiresistant epidemic
Iberian clone. Screening ofGISA strains has been routinely performed in all
S. aureus (221 MRSA and 1430 MSSA) isolated since Jan 1998 to Dec 1999
and in a selected sample of244 MRSA strains isolated in the 1990-97 period,
by using plates with 2, 4 and 6 mg/L of vancomycin (V). No GISA were
detected among MSSA strains. The prevalence of GISA among MRSA
strains was 27.7% in 1990-94.14% in 1995-97,6.2% in 1998 and 1.8% in
1999. All GISA strains belonged to Iberian clone, showed MICs of4 mg/L of
V and were confirmed by population analysis profiles. The MRSA infection
control program was initiated in Feb-90 and was based on: 1) Clinical
laboratory-based surveillance 2) Isolation measures and reinforcement of
hand washing and 3) Mupirocine treatment ofMRSA carriers (pts and hew).
The monthly incidence rate decreased from a mean of0.57 cases/l 00 adm. in
the 1990-94 period to 0.33 cases/loo adm. in the 1996-98 period (p =
0.(04). A decrease in V use was observed from 1995 to 1998. The decrease in
the frequency of GISA strains in our hospital could be related to the
reduction of glycopeptide use, the efficacy of control measures and the
emergence ofa new MRSA clone with MIC of 1 mg/L ofV and susceptible
to gentamicin.
In conclusion, specific MRSA infection control programmes, rational
antibiotic policies including reduction ofglycopeptide use and good practice
are the key measures in reducing hospital acquired MRSA and GISA
infections. Active surveillance for MRSA and GISA must be maintained.
IMoS291 Therapeutic options for GISA
Alan P. Johnson
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Isolates of GISA reported to date have been obtained from patients who
failed treatment with vancomycin. Although the number ofpatients is small,
the repeated observation oftreatment failure indicates that agents other than
glycopeptides should be used to treat infections due to GISA.
The widespread concept of vancomycin as the "drug of last resort" for
MRSA, has lead many to suggest that emergence of vancomycin resistance
in MRSA would equate with untreatable infections. However. some GISA
isolates have remained susceptihle to a range of agents such as co-trimox-
azoic, gentamicin, tetracycline, chloramphenicol, rifampicin or quinupris-
tin/dalfopristin. Some patients with GISA infections have apparently been
successfully treated with non-glycopeptide agents, although additional
treatment components such as surgical intervention make assessment of
their efficacy difficult. Nevertheless, it would seem prudent to recommend
that therapy of infections with GISA be guided by the results of laboratory
susceptibiliTy testing. If necessary, this should inelude developmental agents
such as oxazolidinones. Laboratory studies with one clinical GISA isolate
have suggested a synergistic interaction between beta-Iactams and vanco-
mycin The role of combination therapy with these or other agents thus
merits further evaluation in vitro and in animal models. Should these or
other treatment options appear favourable. their successful clinical applica-
tion will depend on the rapid and reliable detection ofJow-level glycopep-
tide resistance in clinical isolates.,
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IMoS30IMolecular tools for epidemiology
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The advent of molecular genotyping has provided a new basis for microbial
epidemiology. The most powerful tools in virology in this context to date
have been PCR based methods such as random amplified polymorphism
detection (RAPD) and PCR combined with restriction enzyme analysis
(PCR-REA) or DNA sequencing. More recently, multilocus sequence
Typing (MLST) has been introduced to provide improved resolution of
bacterial isolates and contributed to databases for the identification and
tracking of the global spread of virulent or drug-resistant pathogens. This
approach would be most suitable for viral pathogens. Molecular methods
have successfully been applied to solve questions on the epidemiology and
dissemination of viral infections of miscellaneous origin. Multiplex assays
detecting multiple agents and markers provide a rational basis for strain
typing. The use of these techniques to monitor drug resistance, mechanisms
and emergence ofinfectious disease by sequence polymorphisms has become
increasingly important. Patterns of drug resistance markers should be
correlated with the epidemiologic findings.
IMoS33! Hepatitis viruses
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Hepatitis A, a childhood infection in the developing world but disappearing
in Europe, readily spreads by the feco-oral route in closed settings and may
remain unrecognized ifanicteric. Occasional transmission has been reported
via blood or blood products. However, gammaglobulin or vaccination can
stop outbreaks.
Hepatitis B and C share the intravenous route of transmission and both
have previously been transmitted to multi-transfused children with leuke-
mia and thalassemia. Recently, we described two outbreaks ofhepatitis C in
a pediatric oncology service including 10 HCV genotype 3a cases (1990-3),
and 10 HCV genotype Ib cases (1993-4). Genetic analysis showed that only
a few strains had spread between the children. Many had high vira1 titres but
remained anti-HCV negative for long periods. Our analysis indicated that
transmission had occurred through violations of hygienic routines when
permanent intravenous catheters were flushed with fluids from contami-
nated multidose vials. This was supported by a closely monitored transmis-
sion event involving a child who became HCV genotype 3a infected when
treated at a ward for adults. In January 1995 all infected children were
transferred to the Department of Infectious Diseases. In parallel, hygienic
routines at thc oncology service were thoroughly overhauled, and no further
cases have occurred.
Our studies highlight the ease of spreading hepatitis C between patients
with intravenous catheters and who are exposed to multidose vials. in
particular if patients are immunosuppressed. Similar transmission mechan-
isms are also relevant for other blood borne agents like HBV, HIV and
malaria. etc.
